FDA Approves Revolutionary Sound Wave Treatment for Cancer

The FDA has approved a non-invasive technique called histotripsy, developed at the University of Michigan, for the treatment of certain cancers. The technique uses focused ultrasound pulses to destroy targeted tissue without affecting the surrounding area. The tool, called Edison, has initially been approved for liver tissue and cancer treatment. It offers a faster recovery time, no scars, and does not require sedation. The researchers believe it could revolutionize surgery and potentially be combined with systemic therapies for a synergistic effect. Histotripsy treatments have also shown potential in stimulating the immune system to identify cancerous cells. The tool's potential is seen as a game-changer in the field of medicine.